Samsara BioCapital’s Kronos Bio KRON Stock Holding History

Samsara BioCapital’s Portfolio KRON Stock Details KRON Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-78,131	Closed	-$64.5K	–	34
2025 Q1	$64.5K	Hold	78,131	–	–	0.01%	34
2024 Q4	$74.2K	Hold	78,131	–	–	0.01%	40
2024 Q3	$78.1K	Hold	78,131	–	–	0.02%	39
2024 Q2	$96.9K	Hold	78,131	–	–	0.02%	37
2024 Q1	$102K	Hold	78,131	–	–	0.02%	36
2023 Q4	$97.7K	Hold	78,131	–	–	0.02%	38
2023 Q3	$102K	Hold	78,131	–	–	0.03%	39
2023 Q2	$134K	Hold	78,131	–	–	0.02%	45
2023 Q1	$114K	Hold	78,131	–	–	0.02%	53
2022 Q4	$127K	Hold	78,131	–	–	0.03%	52
2022 Q3	$262K	Hold	78,131	–	–	0.06%	51
2022 Q2	$284K	Hold	78,131	–	–	0.08%	52
2022 Q1	$565K	Hold	78,131	–	–	0.14%	53
2021 Q4	$1.06M	Hold	78,131	–	–	0.21%	43
2021 Q3	$1.64M	Hold	78,131	–	–	0.26%	41
2021 Q2	$1.87M	Sell	78,131 -88,119	-53%	-$2.23M	0.23%	44
2021 Q1	$4.87M	Hold	166,250	–	–	0.9%	27
2020 Q4	$4.97K	Buy	+166,250	New	+$5.22M	0.5%	23

Samsara BioCapital's KRON Position: Q2 2025 in Review

Samsara BioCapital sold out of Kronos Bio (KRON) in Q2 2025, closing a stake of 78,131 shares — an estimated $64.5K sold.

Samsara BioCapital first reported a position in KRON in Q4 2020 and held it in 18 quarters. The position peaked at $4.87M in Q1 2021. 0 funds tracked by Wall St. Rank hold KRON as of Q2 2025.

Samsara BioCapital reported no remaining Kronos Bio position as of Q2 2025 after selling out during the quarter.
Samsara BioCapital sold 78,131 Kronos Bio shares in Q2 2025, an estimated $64.5K.
Samsara BioCapital first reported a position in Kronos Bio in Q4 2020 and held it in 18 quarters.
Samsara BioCapital's Kronos Bio position peaked at $4.87M in Q1 2021.
0 funds tracked by Wall St. Rank held Kronos Bio as of Q2 2025.

Based on Samsara BioCapital's 13F filing for Q2 2025, filed 14 Aug 2025.